(Q40184010)
Statements
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation (English)
Howard I Scher
Deborah L Marrocco
Andreas Evdokiou
Richard A Rifkind
Paul A Marks
Victoria M Richon
11 January 2007